These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34328110)

  • 1. CRISPR: History and perspectives to the future.
    Kozovska Z; Rajcaniova S; Munteanu P; Dzacovska S; Demkova L
    Biomed Pharmacother; 2021 Sep; 141():111917. PubMed ID: 34328110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and diagnostic relevance of Crispr technology.
    El Ouar I; Djekoun A
    Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.
    Smargon AA; Shi YJ; Yeo GW
    Nat Cell Biol; 2020 Feb; 22(2):143-150. PubMed ID: 32015437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications.
    Mills EM; Barlow VL; Luk LYP; Tsai YH
    Cell Biol Toxicol; 2020 Feb; 36(1):17-29. PubMed ID: 31418127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in genome editing of stem cells for drug discovery and therapeutic application.
    Lee J; Bayarsaikhan D; Bayarsaikhan G; Kim JS; Schwarzbach E; Lee B
    Pharmacol Ther; 2020 May; 209():107501. PubMed ID: 32061705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System.
    Bellizzi A; Ahye N; Jalagadugula G; Wollebo HS
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):578-594. PubMed ID: 31512166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
    Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
    Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson's Disease.
    Luo J; Padhi P; Jin H; Anantharam V; Zenitsky G; Wang Q; Willette AA; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):595-607. PubMed ID: 30879240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
    Campbell LA; Richie CT; Maggirwar NS; Harvey BK
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime Editing: A Novel Cas9-Reverse Transcriptase Fusion May Revolutionize Genome Editing.
    Flotte TR; Gao G
    Hum Gene Ther; 2019 Dec; 30(12):1445-1446. PubMed ID: 31860398
    [No Abstract]   [Full Text] [Related]  

  • 20. The expanding footprint of CRISPR/Cas9 in the plant sciences.
    Schaeffer SM; Nakata PA
    Plant Cell Rep; 2016 Jul; 35(7):1451-68. PubMed ID: 27137209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.